Paroxetine during lactation: Is it really safe for the infant?

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 10, 2004, Pages 1406-1407

  De Vries, T W ^a   De Jong Van De Berg, L T W ^b   Hadders Algra, M ^c  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BREAST FEEDING; CHILD DEVELOPMENT; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MILK LEVEL; DRUG SAFETY; HUMAN; LACTATION; LETTER; MENTAL DEVELOPMENT; NEUROTOXICITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUERPERAL DEPRESSION; TERATOGENICITY; WEIGHT GAIN;

FEMALE; HUMANS; LACTATION; MILK, HUMAN; PAROXETINE; SAFETY; SEROTONIN UPTAKE INHIBITORS;

EID: 4644271740     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410018292     Document Type: Letter

References (16)

1. Bourin M, Chue P, Guillon C. Paroxetine: a review. CNS Drug Rev 2001; 7: 25-47
2. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-89
3. Mirmiran M, Brenner E, Van der Gugten J, et al. Neurochemical and electrophysiological disturbances mediate developmental behavioural alterations produced by medicines. Neurobehav Toxicol Teratol 1985; 7: 677-83
4. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001; 65: 21-37
5. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113: 368-75
6. Spigset O, Carleborg L, Norstrom A, et al. Paroxetine level in breast milk. [letter] J Clin Psychiatry 1996; 57: 39
7. Begg EJ, Duffull SB, Saunders DA, et al. Paroxetine in human milk. Br J Clin Pharmacol 1999; 48: 142-7
8. Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000; 157: 185-9
9. Ohman R, Hagg S, Carleborg L, et al. Excretion of paroxetine into breast milk. J Clin Psychiatry 1999; 60: 519-23
10. Misri S, Kim J, Riggs KW, et al. Paroxetine levels in postpartum depressed women, breast milk and infant serum. J Clin Psychiatry 2000; 61: 828-32
11. Hendrick V, Stowe ZN, Altshuler LL, et al. Paroxetine use during breast-feeding. [letter] J Clin Psychopharmacol 2000; 20: 587-8
12. Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999; 104: e11
13. Hendrick V, Fukuchi A, Altshuler LL, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001; 179: 163-6
14. Merlob P, Stahl B, Sulkes J. Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004; 24: 135-9
15. Nurnberg HG. Breast feeding and psychotropic agents. Am J Psychiatry 1981; 138: 120-1
16. Hadders-Algra M, Klip-Van den Nieuwendijk A, Martijn A, et al. Assessment of general movements: towards a better understanding of a sensitive method to evaluate brain function in young infants. Dev Med Child Neurol 1997; 39: 89-99